Table 3 Adjusted odds ratios including the 95% CI and the p-value for the severity and mortality endpoint for (A) sarcopenia marker and (B) cardiac marker.

From: Biomarkers extracted by fully automated body composition analysis from chest CT correlate with SARS-CoV-2 outcome severity

(A)

Severity

Mortality

Features

OR

95% CI

p-value

OR

95% CI

p-value

Sarcopenia marker

0.42

[0.23, 0.78]

0.006

0.34

[0.17, 0.67]

0.002

CRP

2.15

[1.79, 2.59]

 ≤ 0.0001

1.67

[1.36, 2.06]

 ≤ 0.0001

Leukocytes

1.60

[1.20, 2.15]

 ≤ 0.001

1.51

[1.08, 2.09]

0.015

Hemoglobin

0.19

[0.11, 0.30]

 ≤ 0.0001

0.10

[0.05, 0.17]

 ≤ 0.0001

ALAT

1.32

[1.05, 1.65]

0.016

1.14

[0.87, 1.47]

0.337

Age

1.01

[1.00, 1.01]

0.226

1.03

[1.02, 1.04]

 ≤ 0.0001

Sex

0.69

[0.49, 0.96]

0.027

0.74

[0.50, 1.08]

0.121

(B)

Severity

Mortality

Features

OR

95% CI

p-value

OR

95% CI

p-value

Cardiac marker

1.42

[1.06, 1.89]

0.018

1.19

[0.85, 1.67]

0.311

CRP

2.16

[1.80, 2.59]

 ≤ 0.0001

1.69

[1.37, 2.07]

 ≤ 0.0001

Leukocytes

1.65

[1.22, 2.21]

 ≤ 0.001

1.51

[1.08, 2.09]

0.015

Hemoglobin

0.20

[0.11, 0.34]

 ≤ 0.0001

0.09

[0.04, 0.16]

 ≤ 0.0001

ALAT

1.31

[1.04, 1.64]

0.019

1.08

[0.83, 1.40]

0.538

Age

1.01

[1.00, 1.02]

0.018

1.05

[1.03, 1.05]

 ≤ 0.0001

Sex

0.85

[0.62, 1.17]

0.324

0.90

[0.62, 1.30]

0.577

Back to article page